ArticlePLOS digital health2025
Exploring perspectives on digital smoking cessation just-in-time adaptive interventions: A focus group study with adult smokers and smoking cessation professionals.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Exploring the Receptivity and Feasibility of Just-In-Time Support for Healthy Food Choices: Mixed-Method Insights for Adaptive Intervention Development.Current developments in nutrition · 2026Article
- Article
- Just-In-Time Adaptive Interventions for Weight Management Among Adults With Excess Body Weight: Scoping Review.Journal of medical Internet research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Technology-mediated just-in-time adaptive interventions (JITAIs), which provide users with real-time, tailored behavioural support, are a promising innovation for smoking cessation. However, a greater understanding of stakeholder, including user, perspectives on JITAIs is needed. Focus groups with UK-based adult smokers (three groups; N = 19) and smoking cessation professionals (one group; N = 5) were conducted January-June 2024. Topic guides addressed the integration of a JITAI into users' lives, preferred content and features, and data and privacy. Transcripts were analysed using inductive and deductive Framework Analysis; deductive codes were derived from the Theoretical Domains Framework and the Technology Acceptance Model. Four co-equal major themes, "Smoking Cessation Process", "JITAI Characteristics", "Perceived Value of the JITAI", and "Relationship with the JITAI", and 16 subordinate themes were identified. The smoking cessation process was described as a challenging and idiosyncratic, non-linear journey during which a JITAI should provide consistent support. Preferences for specific JITAI characteristics varied. However, participants consistently expressed that a JITAI should be highly personalised and offer both immediate, interruptive support and ambient, in-depth content. The perceived usefulness and ease of use of a JITAI were described as central to its perceived value. Participants stressed that a JITAI would need to be convenient enough to easily integrate into users' daily lives, yet disruptive enough to facilitate behaviour change. Smokers expressed that they would want their relationship with a JITAI to feel supportive and non-judgmental. They also felt a JITAI should promote their autonomy. Smoking cessation professionals stressed the importance of privacy and data protection, whereas smokers appeared more ambivalent and had mixed opinions about this topic. JITAIs need to balance aspects of competing demands in their design, such as optimising for both convenience and sufficient disruption, promoting autonomy, and integrating interruptive and ambient content while also meeting stakeholder needs and expectations in terms of privacy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.